Eurofins Medical Device Testing network of laboratories offers multiple state-of-the-art technologies and approaches to Identification (ID) Testing to provide the appropriate level of identification to fit your needs. From identification of environmental isolates, through to expert analysis of finished product contaminants, we offer the most comprehensive ID services available for bacteria, moulds and yeasts.
We also offer typing services to trace the source and investigate the root cause of contamination by establishing the unique fingerprint of microorganisms.
Bacteria: 16S rRNA Gene Long Sequencing
Uses PCR to amplify more than 1,350 base pairs, double strand sequencing and comparison to our validated, proprietary database, Eurofins Microbial Sequencing Index (EMSI), including more than 8,450 valid type strains.
Fungi: 25S rRNA Gene or ITS1/ITS2 Partial Sequencing
Uses 25S rRNA gene.
Multilocus Comparative Sequencing (MLSA)
Solves drawbacks from 16S rRNA (bacteria) or 25S rRNA genes, ITS1 and/or ITS2 (fungi), sequencing by increasing resolution to further discriminate at the species level.
Generates fingerprints of bacterial and fungal isolates in order to determine strain similarities for critical investigations, such as media fill and sterility test failures. Typing methodologies available, including:
Eurofins Medical Device Testing's methods follow the most current requirements outlined in:
Microbial identification and typing are methods to determine the identity and characteristics of microorganisms, such as bacteria, fungi, and viruses
Microbial identification and typing are important in medical devices because they can help to ensure the quality and safety of the products and prevent contamination and infection.